ABSTRACT
The use of laparoscopy in the treatment of malignant disease has generated a great deal of controversy, in part, due to the fear of inadequate cancer control. The early laparoscopic experience cited in the surgical and gynecological literature initially elevated concerns regarding the risk of port site recurrence. Indeterminate surgical margins and loss of precise pathological staging information due to morcellation historically increased these concerns. In urologic surgery, minimally invasive procedures for malignant disease have shown equivalent cancer control when compared to traditional open approaches.
